Clinical Study Support by Long-Term Stability Studies of Alpha₁-Proteinase Inhibitor and Urea in Relevant Biological Matrices

<b>Background/Objectives</b>: According to recent guidelines, including the guideline on bioanalytical method validation issued by the European Medicine Agency, the stability of clinical analytes should be known. We summarize human α₁-proteinase inhibitor (A1PI) an...

詳細記述

書誌詳細

出版年:	Pharmaceuticals
主要な著者:	Andrea Engelmaier, Martin Zimmermann, Harald A. Butterweck, Alfred Weber
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2025-04-01
主題:	α<sub>1</sub>-proteinase inhibitor α<sub>1</sub>-antitrypsin functional activity immunological protein measurement long-term analyte stability clinical study
オンライン･アクセス:	https://www.mdpi.com/1424-8247/18/4/572